West Pharmaceutical Services, Inc.
Financials
Valuation Metrics
West Pharmaceutical Services, Inc.'s Market Cap is $24.59B. At end of 2025 it was $19.87B. Ranked #540 of 3,112 in US market (top 17%), #376 of 1,667 on NYSE (top 23%), #37 of 206 in Health Care Equipment & Services (top 18%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $24.59B | US#540/3,112 Sec#37/206 |
| Revenue | $3.33B | US#1,159/3,112 Sec#68/206 |
| Net Income | $565M | US#756/3,112 Sec#44/206 |
| Total Assets | $4.08B | US#1,577/3,112 Sec#73/206 |
| Net Assets | $2.99B | US#981/3,112 Sec#51/206 |
| Employees | 10,800 | US#575/3,112 Sec#57/206 |
| Value | ||
| P/E | 43.53x | US#1,766/3,112 Sec#85/206 |
| P/B | 8.22x | US#2,509/3,112 Sec#163/206 |
| PEG | 2.58x | US#1,108/3,112 Sec#52/206 |
| P/S | 7.39x | US#2,529/3,112 Sec#179/206 |
| EV/EBITDA | 29.69x | US#2,167/3,112 Sec#116/206 |
| FCF Yield | 1.78% | US#2,002/3,112 Sec#129/206 |
| Profitability | ||
| ROE | 18.89% | US#631/3,112 Sec#31/206 |
| ROA | 13.86% | US#241/3,112 Sec#15/206 |
| Op. Margin | 20.64% | US#875/3,112 Sec#29/206 |
| Revenue Growth | 13.85% | US#1,029/3,112 Sec#69/206 |
| Earnings Growth | 16.84% | US#993/3,112 Sec#49/206 |
| Financial Health | ||
| Debt Ratio | 36.33% | US#414/3,112 Sec#48/206 |
| Total Debt | $312M | US#2,024/3,112 Sec#106/206 |
| FCF | $437M | US#922/3,112 Sec#53/206 |
| Cash | $436M | US#1,162/3,112 Sec#70/206 |
| Current Ratio | 2.82x | US#872/3,112 Sec#92/206 |
| Net Debt/EBITDA | -0.15x | US#564/3,112 Sec#39/206 |
| Dividend | ||
| Div. Yield | 0.25% | US#1,609/3,112 Sec#49/206 |
| Div. Growth | 4.56% | US#844/3,112 Sec#31/206 |
| Performance | ||
| 1Y Return | 45.74% | US#819/3,112 Sec#58/206 |
| 1M Return | -4.82% | US#2,224/3,112 Sec#144/206 |
| From 52W High | -9.82% | US#1,027/3,112 Sec#73/206 |
| 1Y MDD | -24.70% | US#1,014/3,112 Sec#26/206 |
| Trading | ||
| Volume | 478,597 shares | US#2,110/3,112 Sec#157/206 |
| Trading Value | $166M | US#602/3,112 Sec#46/206 |
| Per Share | ||
| EPS | $6.83 | US#440/3,112 Sec#32/206 |
| BPS | $43.93 | US#508/3,112 Sec#34/206 |
Company Info
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.